Artesunate, an antimalarial medication, is widely available globally. It is listed on the World Health Organization's List of Essential Medicines, which highlights medications that are crucial for addressing public health needs [1].
According to the Drug Patent Watch website, there are multiple manufacturers producing artesunate, and it is available in various countries [2]. This suggests that there is a global supply of artesunate, making it accessible to those who need it.
The Centers for Disease Control and Prevention (CDC) also acknowledges the availability of artesunate for the treatment of severe malaria. They recommend using artesunate as the preferred treatment option for severe malaria, as it has shown better efficacy and lower mortality rates compared to other antimalarial drugs [3].
Furthermore, the National Center for Biotechnology Information (NCBI) states that artesunate is available in different formulations, including injectable and oral forms, making it suitable for various treatment settings [4]. This indicates that artesunate can be used in different healthcare settings, including hospitals and community health centers.
In conclusion, based on the provided sources, artesunate is widely available globally. It is listed as an essential medicine, multiple manufacturers produce it, and it is recommended by the CDC for the treatment of severe malaria. The availability of different formulations also suggests its accessibility in various healthcare settings.
Sources:
[1] World Health Organization. (2019). WHO Model List of Essential Medicines. Retrieved from https://www.who.int/medicines/publications/essentialmedicines/en/
[2] Drug Patent Watch. (n.d.). Artesunate. Retrieved from https://www.drugpatentwatch.com/p/tradename/ARTESUNATE
[3] Centers for Disease Control and Prevention. (2021). Discontinuation of Artesunate for Severe Malaria Treatment in the United States. Retrieved from https://www.cdc.gov/malaria/diagnosis_treatment/discontinuation_artesunate.html
[4] National Center for Biotechnology Information. (2004). Antimalarial Agents. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK1713/